D. Thibout

Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.

M. Crépin, M. Kraemer, L. Saffar, 1999, Anticancer research.

Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules

C. Soria, M. Crépin, M. Vasse, 2001, British Journal of Cancer.

Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.

M. Crépin, M. Kraemer, M. Di Benedetto, 1998, Anticancer research.

Characterization of a new BLM mutation associated with a topoisomerase II alpha defect in a patient with Bloom's syndrome.

A. Barakat, C. Jaulin, P. Planchon, 1997, Human molecular genetics.